
NIB 11mg Tablet XR
Marketer
Zuventus Healthcare Ltd
Salt Composition
Tofacitinib (11mg)
Overview NIB 11mg Tablet XR
XR-11 (11mg extended-release tablets) is indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It alleviates joint pain, tenderness, and swelling by suppressing inflammation and slowing the progression of bone and joint deterioration. XR-11 may be administered alone or in conjunction with other medications. Tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your health status and other medications. Always adhere to your physician's prescribed regimen. Discontinue use only under your doctor's direction, as abrupt cessation may exacerbate your condition. Common side effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse events such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Report any concerns regarding side effects to your doctor. Pre-treatment blood work may be required. Do not initiate treatment if you have an infection. Consult your physician before starting XR-11 if you have or have had tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. XR-11 increases susceptibility to infection and may worsen existing infections; minimize contact with individuals exhibiting contagious illnesses (e.g., varicella, measles, influenza). This medication is contraindicated in patients under 18 years of age and during pregnancy or breastfeeding unless the potential benefits clearly outweigh the risks. Regular medical monitoring may be necessary.
Primary Ingredients of NIB 11mg Tablet XR
No text provided to rephrase.
Uses of NIB 11mg Tablet XR
Managing rheumatoid, psoriatic, and ankylosing spondylitis arthritis, plus ulcerative colitis.
Major Benefits of NIB 11mg Tablet XR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The NIB 11mg Tablet XR can be administered with or without food, although consistent daily timing is recommended.
Common Side effects of NIB 11mg Tablet XR:
- Upper respiratory tract infection
- Headache
- Diarrhea
- Nasopharyngitis (inflammation of the throat and nasal passages)
How to use NIB 11mg Tablet XR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The NIB 11mg Tablet XR can be administered with or without food, though consistent timing is recommended for optimal results.
How NIB 11mg Tablet XR works:
Extended-release NIB 11mg tablets are Janus kinase inhibitors that suppress Janus kinase enzyme activity. This reduces immune system responsiveness and inflammation characteristic of rheumatic conditions and ulcerative colitis.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concomitant alcohol ingestion and NIB 11mg Tablet XR.
PregnancyCONSULT YOUR DOCTOR
Extended-release NIB 11mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release NIB 11mg tablets are likely not suitable for use while breastfeeding. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Extended-release NIB 11mg tablets typically have no impact on driving capabilities.
KidneyCAUTION
Extended-release NIB 11mg tablets require careful administration in individuals with advanced kidney impairment. Dosage modification of NIB 11mg extended-release tablets might be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release NIB 11mg tablets require careful administration in individuals with advanced hepatic impairment. Dosage modification for NIB 11mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take NIB 11mg Tablet XR :
Should you forget to take a scheduled dose of your 11mg extended-release NIB tablet, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About NIB 11mg Tablet XR
| Label | Value |
|---|---|
| Chemical Type | Pyrrolopyrimidine Compound |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
| Action Class | JAK inhibitors |
